Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
Morscher RJ, Brard C, Berlanga P, Marshall LV, André N, Rubino J, Aerts I, De Carli E, Corradini N, Nebchi S, Paoletti X, Mortimer P, Lacroix L, Pierron G, Schleiermacher G, Vassal G, Geoerger B. Morscher RJ, et al. Among authors: vassal g. Eur J Cancer. 2021 Nov;157:268-277. doi: 10.1016/j.ejca.2021.08.010. Epub 2021 Sep 17. Eur J Cancer. 2021. PMID: 34543871 Clinical Trial.
DNA-topoisomerase I, a new target for the treatment of neuroblastoma.
Vassal G, Pondarré C, Cappelli C, Terrier-Lacombe MJ, Boland I, Morizet J, Bénard J, Vénuat AM, Ardouin P, Hartmann O, Gouyette A. Vassal G, et al. Eur J Cancer. 1997 Oct;33(12):2011-5. doi: 10.1016/s0959-8049(97)00296-7. Eur J Cancer. 1997. PMID: 9516844
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation.
Hartmann O, Valteau-Couanet D, Benhamou E, Vassal G, Rubie H, Beaujean F, Lemerle J. Hartmann O, et al. Among authors: vassal g. Eur J Cancer. 1997 Oct;33(12):2126-9. doi: 10.1016/s0959-8049(97)00227-x. Eur J Cancer. 1997. PMID: 9516867
Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy.
Rubie H, Doz F, Vassal G, Chastagner P, Gentet JC, Urien S, Bastian G, Drouard-Troalen L, Barberi-Heyob M, Catalin J, Chatelut E; Pharmacology Group of the Société Française de Pédiatrie Oncologique. Rubie H, et al. Among authors: vassal g. Eur J Cancer. 2003 Jul;39(10):1433-8. doi: 10.1016/s0959-8049(03)00314-9. Eur J Cancer. 2003. PMID: 12826047 Clinical Trial.
342 results